FDA Inspection 949087 — Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
The FDA completed an inspection of Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company on Nov 17, 2015 in Manati, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Manati, PR (United States)